High resolution ultrasound (HRUS) was tested in 58 cutaneous malignant melanomas to check its validity in evaluating tumor thickness in vivo before surgery. The values obtained with this method were compared with histologic values (measured according to Breslow); a highly significant correlation was found (r = 0.895, p less than 0.001). The accuracy of HRUS in distinguishing between low- and high-risk cutaneous malignant melanoma was also found to be quite high. Our data therefore justify the use of such a technique in the preoperative staging procedure.
Nifedipine is a calcium-channel antagonist with effective antihypertensive activity and has been suggested for the treatment of high blood pressure as an alternative to vasodilators. The aim of this study was to define the acute effect of nifedipine and in particular the dose-effect relationship, effects on veins, influence on adrenergic reflexes, and effectiveness on hypertension according to severity and etiologic type. The effects of nifedipine on blood pressure, heart rate, forearm blood flow, peripheral vascular resistance, orthostatic and cold reflexes, and venous tone were examined in 45 patients with hypertension of different etiologies (essential, renovascular, and renal parenchymal) and different World Health Organization grades. The antihypertensive effect was dose dependent, but a dose of 20 mg has nearly maximal activity with acceptable side effects. The drug acts by lowering peripheral vascular resistance, and this lowering is directly related to baseline values; therefore, the antihypertensive effect increases with severity of the hypertension. Nifedipine had the same effect in all three etiologic groups of hypertension studied. The drug seems to increase venous tone, since it caused venoconstriction when locally injected in hand veins. Nifedipine did not alter adrenergic reflexes induced by both cold application and standing and was well tolerated. In conclusion, the calcium antagonist nifedipine for its characteristics of action, at least in acute administration, seems to be a useful alternative in the treatment of various forms of hypertension.
In order to obtain better results with suction-assisted lipectomy (SAL), we developed a new electronic instrument, the skin elasticity analyzer (SEA) for improving patient selection and also for testing our new “anti-skin wave” treatment, a dermopharmaceutical product created for skin elasticity enhancement.
This paper proposes an innovative methodology to estimate the thermal behaviour of the cylindrical gearbox system, considering, as a thermal source, the power loss calculated under transient operating conditions. The power loss of the system in transient conditions is computed through several approaches: a partial elasto-hydrodynamic lubrication model (EHL) is adopted to estimate the friction coefficients of the gears, while analytical and semiempirical models are used to compute other power loss sources. Furthermore, considering a limited set of operating condition points as a training set, a reduced-order model for the evaluation of the power loss based on a neural network is developed. Using this method, it is possible to simulate thermal behaviour with high accuracy through a thermal network approach in all steady-state and transient operating conditions, reducing computational time. The results obtained by means of the proposed method have been compared and validated with the experimental results available in the literature. This methodology has been tested with the FZG rig test gearbox but can be extended to any transmission layout to predict the overall efficiency and component temperatures with a low computational burden.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.